This site uses cookies. For more information, please see our
Privacy Policy
Agree
About
Company
Board
Management
Products
Trogarzo® IV Infusion
Trogarzo® IV Push
TMB-365
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
Antibody-Drug Conjugates, ADCs
CDMO Service
Contract Development and Manufacturing Service (CDMO)
Partners
News
Investor Relations
Company
Company Profile
Corparate Governance
Organization
Board
Committee
Internal Audit
Major Internal Policies
Financials
Monthly Revenue
Financial Reports
Shareholders' Services
Major Shareholders
Dividend Information
Shareholder's Meeting
Institutional Investor Conference Information
Sustainable Development
2023 ESG
MENU
(
En
)
En
繁中
Contact CDMO Service
CLOSE
En
繁中
About
Company
Board
Management
Products
Trogarzo® IV Infusion
Trogarzo® IV Push
TMB-365
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
Antibody-Drug Conjugates, ADCs
CDMO Service
Contract Development and Manufacturing Service (CDMO)
Partners
News
Investor Relations
Company
Company Profile
Corparate Governance
Organization
Board
Committee
Internal Audit
Major Internal Policies
Financials
Monthly Revenue
Financial Reports
Shareholders' Services
Major Shareholders
Dividend Information
Shareholder's Meeting
Institutional Investor Conference Information
Sustainable Development
2023 ESG
CDMO
Home
Contact Us
CDMO
Join TaiMed
Spokesperson
Stakeholders
Investor Relations
Stock Affairs
Complaints Box
CDMO
Join TaiMed
Spokesperson
Stakeholders
Investor Relations
Stock Affairs
Complaints Box
CDMO相關諮詢請至下方留言,我們將盡快與您聯繫~
Name
Tel
E-mail
Memo
Code
Fill in again
Confirm submit
Transferring data. Please wait . . .